DiabetesHappier FeetNCT05865353
Happier Feet- A Smart Insole for Diabetic Foot Ulceration Prevention
An observational study of Diabetes, run by University of Exeter at 1 site in United Kingdom.
Trial summary
This study aims to design, develop, and evaluate a smart insole to predict the formation of diabetic foot ulcers (DFUs) in diabetic participants at risk of developing them. The study will be conducted in two phases, using mixed-method research and engaging both diabetic participants and NHS clinicians. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Diabetes
- How many people
- 20 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 1 Feb 2023to 30 Sep 2023
- How long will I take part?
- 2 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: The study population comprises 20 individuals from both genders, divided into two groups: a Diabetic Group consisting of 10 patients with a confirmed diagnosis of diabetes who are at risk of developing or have a history of diabetic foot ulcer (DFU), and a Healthy Control Group consisting of 10 individuals with no diagnosis of diabetes or movement disorder. The selection criteria for the Diabetic Group include a confirmed diagnosis of diabetes and a history or risk of developing DFU, while the Healthy Control Group includes individuals with no known medical conditions that could affect their movement or balance.
Who may be able to join
- Confirmed diagnosis of diabetes
- 1)At the risk of developing a DFU 2) Able to understand and communicate to safely participate [Brief Assessment of Capacity 3) to have a score at least 6/8 (UBACC)]Capacity to participate 4) capability to walk for 10 mins without rest 5) Be able to walk for 30 minutes with no pain, no walking aid, and take breaks if required.
- 6) Must have sensation on their feet 7) Able to walk without a walking aid or orthotic.
- Above 18 years old
- Able to walk for 30 minutes with no pain, no walking aid, and taking breaks if required.
- No contraindications to walking and physical activity
- No broken skin on the foot
- Do not suffer from a skin condition such as severe eczema or skin allergies.
Who cannot join
- Below 18 years old
- Contradictions to walking and physical activity
- Broken skin on the foot
- Suffering from a skin condition such as severe eczema or skin allergies
- Pain affecting the ability to walk.
- Healthy participants
Show all 11Show fewer
- below 18 years old
- Any movement disorder
- Pain during the walk
- Broken skin on the foot.
- suffer from a skin condition such as severe eczema or skin allergies.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Happier Feet- Disrupting the Vicious Cycle of Healthcare Decline in Diabetic Foot Ulceration Through Active Prevention: The Future of Self-managed Care
This study aims to design, develop, and evaluate a smart insole to predict the formation of diabetic foot ulcers (DFUs) in diabetic participants at risk of developing them. The study will be conducted in two phases, using mixed-method research and engaging both diabetic participants and NHS clinicians. In Phase 1, the user-centred design of the smart insole will be developed through focus groups and online questionnaires, and a preliminary safety evaluation of the insole will be conducted with healthy team members. In Phase 2, the insole will be tested, validated, and data will be collected through baseline visits, lab studies, and insole data collection with shape-changed (pressure off-loading) insoles. The study will be conducted by researchers from the University of Manchester and the University of Exeter. It will include 10 people with diabetes and 10 healthy controls in Phase 2.
Read the detailed description
The tasks in this phase will be conducted by researchers from the University of Manchester and the University of Exeter. All tasks will be held at the University of Exeter.
Recruited participants will attend three sessions (tasks) on three non-consecutive days in the span of three months.
Participants will be identified either through participant identifying centres (e.g., Manchester diabetes clinic) or through direct contact from ad response. From these identified patients, lists will be screened by either general practitioners (for National Health Service (NHS) sites) or the University of Manchester and University o Exeter researchers (for direct contact) according to eligibility criteria. Eligible participants will be written to and invited to return a reply slip detailing whether they are interested in taking part. The return slips will contain all necessary details of the study, including participant information sheets. These must be given to eligible participants at least 48 hours before any planned interview sessions.
Eligible participants that return reply slips, or email the research team to say they are interested, will be contacted by phone by a researcher to clarify any questions they may have. The researcher will then notify the participant of the schedule for the sessions. On the arranged date, before the sessions, the participant will complete the consent process.
n = 20 (10 diabetic participants, 10 healthy similar controls)
- Task 2.1 Baseline Visit: Eligibility confirmation and health screening session
- Consented participants will be asked to attend an eligibility confirmation, health evaluation and foot measurements session.
- This includes:
- Two-minute walk to evaluate the walking capability
- Gait and core kinematics evaluation (using IMU sensors and motion capture cameras)
- Physical Activity Readiness questionnaire (PAR-Q) to determine whether the participant is fit to carry out walking-related activities
- Monofilament test of the foot (for neuropathy) - Cutaneous pressure perception will be assessed using a 10 g monofilament at the first, third, and fifth prominent metatarsal heads on each foot, with the absence of sensation at any one site indicating neuropathy.
- Foot measurements and evaluation of anatomical landmarks using a High-Resolution pressure mat (HR-Mat, Tekscan).
- Participants will also have a fitting session for the co-developed pressure-relief smart insole. Participants will be asked to wear the insoles and give feedback on fitting. Data Collection Method:
- Qualitative data Gait and core kinematics evaluation data will be collected in the form of electronic signals (from Intreial Measurement Unit (IMU) sensors) and videos (motion capture cameras) Data collected during the baseline visit will be both qualitative and quantitative.
- Qualitative data:
- Qualitative data may be filled in by the participants at the beginning of the baseline visit or prior to the visit, provided the participants have been given the Participant Information Sheet (PIS) at least 48 hours prior to the visit.
- Qualitative data collected within this task are:
- Signed participant forms - (i) Decisional capacity evaluation, (ii) consent, (iii) inclusion/exclusion ii. Demographic data - age, sex, weight, iii. Physical Activity Readiness Questionnaire (PAR-Q) iv. Researcher notes v. Monofilament foot test for neuropathy - noted as yes/no for neuropathy.
- Quantitative data:
- Quantitative data collected within this task are: i. Gait and core kinematics evaluation: using Inertial Measurement Unit (IMU) sensors (physiobiometric) and motion capture cameras and Azure Kinect (data = video files collected and reviewed in the university-managed computer). This will be analysed using Statistical Package for the Social Sciences (SPSS) v.28 or onwards ii. Foot pressure readings (standing) will be collected via HR-Mat in the form of electronic signals that is collected via the HR-Mat Tekscan Research app in a university-managed laptop.
- Task 2.2 Pilot laboratory - Insole data collection • The first study (Task 2.2) is a pilot evaluation in the lab to collect insole data for a series of activities. The activities are the same between the diabetic and control groups:
- Participants will be asked to wear the smart insole while sitting (10 minutes), standing (5 minutes), and walking on a treadmill at a self-selected normal pace (15 minutes).
- Participants will be asked to repeat the procedure after a 20 minutes rest.
- After repeating the procedure, participants will rest for up to 15 minutes, after which participants will be asked to do a final short 2-5 minute walk on the ground.
- Participants will be asked for feedback on the insole and their experience with the study.
- Participants' health will be monitored throughout the study- heart rate, blood pressure, and blood glucose Data Collection Method:
- Quantitative data Insole data in the form of electronic signals will be collected via the electronic hub (of the insole) and sent via Bluetooth to a university-managed laptop. The data will be recorded and stored in secure folders on the university-managed laptop, followed by further analyses. Participant health (heart rate, blood pressure and blood glucose)
- Qualitative data Qualitative data collected will also be a short questionnaire on the feedback on the usability and acceptability of the insole. Participant satisfaction, experience and feedback on the insole/study will be collected through a questionnaire that can either be answered via an electronic questionnaire or a physical copy.
- Task 2.3 Lab study- insole data collection with shape-changed (pressure shape changed) insole
- The second study (Task 2.3) pilot evaluation in the lab to collect insole data for a series of activities with a bespoke shape-changed insole to offload the pressures of the foot. The procedures (study methods and data collection) will be as follows:
- Participants will be asked to wear the smart insole while sitting (10 minutes), standing (5 minutes), and walking on a treadmill at a self-selected normal pace (15 minutes).
- This is followed by a 20-minute rest. During which, a bespoke shape-changed insole will be fitted prior to the next activity.
- Participants will repeat #1 with the bespoke shape-changed insole.
- After repeating the procedure, participants will rest for up to 15 minutes, after which participants will be asked to do a final short 2-minute walk on the ground.
- Participants will be asked for feedback on the insole and their experience with the study.
- Participants' health will be monitored throughout the study- heart rate, blood pressure, and blood glucose
- Conditions
- Diabetes
- Medical subject headings
- Diabetes Mellitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Diabetes | Ten Diabetic participants at risk of DFU/ in this cross-sectional study, participants will be asked to use the smart insole and complete sitting, standing and walking task | |
| Healthy control | Ten healthy participants without movement disorder or Diabetes. The same tasks (sitting, standing and walking) while wearing the smart insole will be repeated for the control group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Shear data
Shear data The primary outcome measure includes testing the reliability of the smart insole in collecting
- Shear stress data (KPa) while walking at a self-selected speed on the treadmill for 15 minutes
- walking on the floor for 2 minutes.
- standing on the floor for 5 minutes.
Measured: Participant visit is for 90 minutes and data collection is for the (15 minutes walk, 2 minutes and standing still for 5 minutes)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 May 2023
- Study start1 Feb 2023
- Primary completion30 Aug 2023
- Study completion30 Sep 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DiabetesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case crossover
- Time perspective
- Cross-sectional
- Enrolment
- 20 participants (actual)
- Target duration
- 2 Months
Sponsor and investigators
- Lead sponsor
- University of Exeter
- Sponsor type
- University, hospital or other
- Collaborators
- University of Manchester, Loughborough University, University of Southampton, University of Strathclyde
- Responsible party
- Sponsor
- Investigators
- Helen Dawes, PhD, Principal investigator, Professor of Clinical RehabilitationsAndrew Weightman, PhD, Principal investigator, Professor of Medical Mechatronics
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05865353
- Sponsor's protocol ID
- 2021-22-30
- Other IDs
- 307041
- Acronym
- Happier Feet
- Status last verified
- Jul 2024
- First submitted
- 6 Feb 2023
- Last updated
- 24 Jul 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual data will not be shared with other researchers or third party
Study at a glance
From the registry record, last updated by the sponsor on 24 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Happier Feet- Disrupting the Vicious Cycle of Healthcare Decline in Diabetic Foot Ulceration Through Active Prevention: The Future of Self-managed Care
- ClinicalTrials.gov ID
- NCT05865353
- Acronym / sponsor ID
- Happier Feet / 2021-22-30
- Conditions
- Diabetes
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- University of ExeterUniversity, hospital or other
- Collaborators
- University of Manchester, Loughborough University, University of Southampton, University of Strathclyde
- Study start
- 1 Feb 2023 (actual)
- Primary completion
- 30 Aug 2023 (actual)
- Study completion
- 30 Sep 2023 (actual)
- First posted
- 18 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to design, develop, and evaluate a smart insole to predict the formation of diabetic foot ulcers (DFUs) in diabetic participants at risk of developing them. The study will be conducted in two phases, using mixed-method research and engaging both diabetic participants and NHS clinicians. In Phase 1, the user-centred design of the smart insole will be developed through focus groups and online questionnaires, and a preliminary safety evaluation of the insole will be conducted with healthy team members. In Phase 2, the insole will be tested, validated, and data will be collected through baseline visits, lab studies, and insole data collection with shape-changed (pressure off-loading) insoles. The study will be conducted by researchers from the University of Manchester and the University of Exeter. It will include 10 people with diabetes and 10 healthy controls in Phase 2.
Detailed description
The tasks in this phase will be conducted by researchers from the University of Manchester and the University of Exeter. All tasks will be held at the University of Exeter.
Recruited participants will attend three sessions (tasks) on three non-consecutive days in the span of three months.
Participants will be identified either through participant identifying centres (e.g., Manchester diabetes clinic) or through direct contact from ad response. From these identified patients, lists will be screened by either general practitioners (for National Health Service (NHS) sites) or the University of Manchester and University o Exeter researchers (for direct contact) according to eligibility criteria. Eligible participants will be written to and invited to return a reply slip detailing whether they are interested in taking part. The return slips will contain all necessary details of the study, including participant information sheets. These must be given to eligible participants at least 48 hours before any planned interview sessions.
Eligible participants that return reply slips, or email the research team to say they are interested, will be contacted by phone by a researcher to clarify any questions they may have. The researcher will then notify the participant of the schedule for the sessions. On the arranged date, before the sessions, the participant will complete the consent process.
n = 20 (10 diabetic participants, 10 healthy similar controls)
- Task 2.1 Baseline Visit: Eligibility confirmation and health screening session
- Consented participants will be asked to attend an eligibility confirmation, health evaluation and foot measurements session.
- This includes:
- Two-minute walk to evaluate the walking capability
- Gait and core kinematics evaluation (using IMU sensors and motion capture cameras)
- Physical Activity Readiness questionnaire (PAR-Q) to determine whether the participant is fit to carry out walking-related activities
- Monofilament test of the foot (for neuropathy) - Cutaneous pressure perception will be assessed using a 10 g monofilament at the first, third, and fifth prominent metatarsal heads on each foot, with the absence of sensation at any one site indicating neuropathy.
- Foot measurements and evaluation of anatomical landmarks using a High-Resolution pressure mat (HR-Mat, Tekscan).
- Participants will also have a fitting session for the co-developed pressure-relief smart insole. Participants will be asked to wear the insoles and give feedback on fitting. Data Collection Method:
- Qualitative data Gait and core kinematics evaluation data will be collected in the form of electronic signals (from Intreial Measurement Unit (IMU) sensors) and videos (motion capture cameras) Data collected during the baseline visit will be both qualitative and quantitative.
- Qualitative data:
- Qualitative data may be filled in by the participants at the beginning of the baseline visit or prior to the visit, provided the participants have been given the Participant Information Sheet (PIS) at least 48 hours prior to the visit.
- Qualitative data collected within this task are:
- Signed participant forms - (i) Decisional capacity evaluation, (ii) consent, (iii) inclusion/exclusion ii. Demographic data - age, sex, weight, iii. Physical Activity Readiness Questionnaire (PAR-Q) iv. Researcher notes v. Monofilament foot test for neuropathy - noted as yes/no for neuropathy.
- Quantitative data:
- Quantitative data collected within this task are: i. Gait and core kinematics evaluation: using Inertial Measurement Unit (IMU) sensors (physiobiometric) and motion capture cameras and Azure Kinect (data = video files collected and reviewed in the university-managed computer). This will be analysed using Statistical Package for the Social Sciences (SPSS) v.28 or onwards ii. Foot pressure readings (standing) will be collected via HR-Mat in the form of electronic signals that is collected via the HR-Mat Tekscan Research app in a university-managed laptop.
- Task 2.2 Pilot laboratory - Insole data collection • The first study (Task 2.2) is a pilot evaluation in the lab to collect insole data for a series of activities. The activities are the same between the diabetic and control groups:
- Participants will be asked to wear the smart insole while sitting (10 minutes), standing (5 minutes), and walking on a treadmill at a self-selected normal pace (15 minutes).
- Participants will be asked to repeat the procedure after a 20 minutes rest.
- After repeating the procedure, participants will rest for up to 15 minutes, after which participants will be asked to do a final short 2-5 minute walk on the ground.
- Participants will be asked for feedback on the insole and their experience with the study.
- Participants' health will be monitored throughout the study- heart rate, blood pressure, and blood glucose Data Collection Method:
- Quantitative data Insole data in the form of electronic signals will be collected via the electronic hub (of the insole) and sent via Bluetooth to a university-managed laptop. The data will be recorded and stored in secure folders on the university-managed laptop, followed by further analyses. Participant health (heart rate, blood pressure and blood glucose)
- Qualitative data Qualitative data collected will also be a short questionnaire on the feedback on the usability and acceptability of the insole. Participant satisfaction, experience and feedback on the insole/study will be collected through a questionnaire that can either be answered via an electronic questionnaire or a physical copy.
- Task 2.3 Lab study- insole data collection with shape-changed (pressure shape changed) insole
- The second study (Task 2.3) pilot evaluation in the lab to collect insole data for a series of activities with a bespoke shape-changed insole to offload the pressures of the foot. The procedures (study methods and data collection) will be as follows:
- Participants will be asked to wear the smart insole while sitting (10 minutes), standing (5 minutes), and walking on a treadmill at a self-selected normal pace (15 minutes).
- This is followed by a 20-minute rest. During which, a bespoke shape-changed insole will be fitted prior to the next activity.
- Participants will repeat #1 with the bespoke shape-changed insole.
- After repeating the procedure, participants will rest for up to 15 minutes, after which participants will be asked to do a final short 2-minute walk on the ground.
- Participants will be asked for feedback on the insole and their experience with the study.
- Participants' health will be monitored throughout the study- heart rate, blood pressure, and blood glucose
Study design
- Observational model
- Case crossover
- Time perspective
- Cross-sectional
- Target follow-up
- 2 Months
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Diabetes | – | –Ten Diabetic participants at risk of DFU/ in this cross-sectional study, participants will be asked to use the smart insole and complete sitting, standing and walking task |
| Healthy control | – | –Ten healthy participants without movement disorder or Diabetes. The same tasks (sitting, standing and walking) while wearing the smart insole will be repeated for the control group |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The study population comprises 20 individuals from both genders, divided into two groups: a Diabetic Group consisting of 10 patients with a confirmed diagnosis of diabetes who are at risk of developing or have a history of diabetic foot ulcer (DFU), and a Healthy Control Group consisting of 10 individuals with no diagnosis of diabetes or movement disorder. The selection criteria for the Diabetic Group include a confirmed diagnosis of diabetes and a history or risk of developing DFU, while the Healthy Control Group includes individuals with no known medical conditions that could affect their movement or balance.
Key inclusion criteria (8 listed)
- Confirmed diagnosis of diabetes
- 1)At the risk of developing a DFU 2) Able to understand and communicate to safely participate [Brief Assessment of Capacity 3) to have a score at least 6/8 (UBACC)]Capacity to participate 4) capability to walk for 10 mins without rest 5) Be able to walk for 30 minutes with no pain, no walking aid, and take breaks if required.
- 6) Must have sensation on their feet 7) Able to walk without a walking aid or orthotic.
- Above 18 years old
- Able to walk for 30 minutes with no pain, no walking aid, and taking breaks if required.
Key exclusion criteria (11 listed)
- Below 18 years old
- Contradictions to walking and physical activity
- Broken skin on the foot
- Suffering from a skin condition such as severe eczema or skin allergies
- Pain affecting the ability to walk.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Shear data
Time frame: Participant visit is for 90 minutes and data collection is for the (15 minutes walk, 2 minutes and standing still for 5 minutes)
Shear data The primary outcome measure includes testing the reliability of the smart insole in collecting 1. Shear stress data (KPa) while walking at a self-selected speed on the treadmill for 15 minutes 2. walking on the floor for 2 minutes. 3. standing on the floor for 5 minutes.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Jul 2024.
- Individual participant dataSharing planned: No. Individual data will not be shared with other researchers or third party
Related trials for Diabetes
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
Hyperglycaemia (Non Diabetic), Prediabetes
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Helen Dawes, PhD principal investigator
Professor of Clinical Rehabilitations
Andrew Weightman, PhD principal investigator
Professor of Medical Mechatronics
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Diabetes, run by University of Exeter at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Shear data (time frame: Participant visit is for 90 minutes and data collection is for the (15 minutes walk, 2 minutes and standing still for 5 minutes)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2024.